97-9988. National Cancer Institute; Notice of Meeting  

  • [Federal Register Volume 62, Number 75 (Friday, April 18, 1997)]
    [Notices]
    [Pages 19122-19123]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 97-9988]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    National Institutes of Health
    
    
    National Cancer Institute; Notice of Meeting
    
        Pursuant to Section 10(d) of the Federal Advisory Committee Act, as 
    amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
    meeting of the National Cancer Institute Frederick Cancer Research and 
    Development Center Advisory Committee.
        The open portion of the meeting will be limited to space available. 
    Individuals who plan to attend and need special assistance, such as 
    sign language interpretation or other reasonable accommodations, should 
    notify the contact person in advance of the meeting.
        Committee Name: Frederick Cancer Research and Development Center 
    Advisory Committee.
        Date: June 9-10, 1997.
        Place: Frederick Cancer Research and Development Center, Building 
    549, Executive Board Room, Frederick, Maryland.
        Open: June 9--8:30 a.m.-10:00 a.m.
        Agenda: Discussion of administrative matters such as future 
    meetings, budget, and information items related to the operation of the 
    NCI Frederick Cancer Research and Development Center.
        Closed: June 9--10 a.m. to recess; June 10-8:30 a.m. to 
    adjournment.
        Agenda/Purpose: Discussion of previous site visit report and 
    response for the Molecular Virology and Carcinogenesis Laboratory 
    review held December 17-18, 1996. The majority of the closed session 
    will be devoted to a site review of the Gene Regulation and Chromosome 
    Biology Laboratory with ABL-Basic Research Program Contract. Also 
    included is a re-review of the Molecular Aspects of Drug Design 
    Section, Macromolecular Structure Laboratory with ABL-Basic Research 
    Program Contract.
        Contact Person: Cedric W. Long, Ph.D., Frederick Cancer Research 
    and Development Center, P.O. Box B,
    
    [[Page 19123]]
    
    Frederick, MD 21702, Telephone: 301-846-1108.
        The meeting will be closed in accordance with the provisions set 
    forth in sections 552b(c)(4) and 552b(c)(6), Title 5, U.S.C. The report 
    and the discussions could reveal confidential trade secrets or 
    commercial property such as a patentable material and personal 
    information concerning individuals associated with the programs, 
    disclosure of which constitute a clearly unwarranted invasion of 
    personal privacy.
    
    (Catalog of Federal Domestic Assistance Program Numbers: 93.393, 
    Cancer Cause and Prevention Research; 93.394, Cancer Detection and 
    Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, 
    Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, 
    Cancer Research Manpower; 93.399, Cancer Control)
    
        Dated: April 11, 1997.
    LaVerne Y. Springfield,
    Committee Management Officer, NIH.
    [FR Doc. 97-9988 Filed 4-17-97; 8:45 am]
    BILLING CODE 4140-01-M
    
    
    

Document Information

Effective Date:
6/9/1997
Published:
04/18/1997
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
97-9988
Dates:
June 9-10, 1997.
Pages:
19122-19123 (2 pages)
PDF File:
97-9988.pdf